We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in IVERIC bio, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 254 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 256 → 0 (-256)

100% less funds holding in top 10

Funds holding in top 10: 40 → 0 (-40)

100% less capital invested

Capital invested by funds: $5.32B → $0 (-$5.32B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 254

Holders
–
Holders Change
-256
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-40
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
254
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$538M
2
BlackRock
BlackRock
New York
-$424M
3
ACA
Avoro Capital Advisors
New York
-$317M
4
UOC
UBS O'Connor
Illinois
-$230M
5
BCM
Beryl Capital Management
California
-$210M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
– -$52.2M -1,327,363 Closed
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
– -$48.6M -1,236,096 Closed
MB
28
MPM BioImpact
Massachusetts
– -$47.8M -1,214,662 Closed
Adage Capital Partners
29
Adage Capital Partners
Massachusetts
– -$45.8M -1,163,140 Closed
N
30
Nuveen
North Carolina
– -$39.9M -1,015,026 Closed
Charles Schwab
31
Charles Schwab
California
– -$39.1M -994,037 Closed
KCM
32
Kingdon Capital Management
New York
– -$38.6M -980,050 Closed
Norges Bank
33
Norges Bank
Norway
– -$37.6M -955,130 Closed
E
34
Ergoteles
New York
– -$34.6M -878,359 Closed
SCM
35
Segantii Capital Management
Hong Kong
– -$34.4M -875,000 Closed
SGCM
36
Sand Grove Capital Management
United Kingdom
– -$34M -865,399 Closed
CC
37
Carlson Capital
Texas
– -$32.8M -835,000 Closed
GCL
38
Glazer Capital LLC
New York
– -$32.5M -826,600 Closed
BC
39
Boxer Capital
California
– -$32.5M -825,000 Closed
FTCM
40
First Trust Capital Management
Illinois
– -$30.6M -778,246 Closed
Hudson Bay Capital Management
41
Hudson Bay Capital Management
Connecticut
– -$30.4M -772,992 Closed
GF
42
Gabelli Funds
New York
– -$30.4M -771,489 Closed
EA
43
Emerald Advisers
Pennsylvania
– -$27.5M -700,046 Closed
GCIA
44
Gabelli & Co Investment Advisers
New York
– -$26.9M -684,950 Closed
Invesco
45
Invesco
Georgia
– -$25.8M -657,083 Closed
DCM
46
DAFNA Capital Management
California
– -$24.1M -612,975 Closed
Marshall Wace
47
Marshall Wace
United Kingdom
– -$23.9M -606,459 Closed
Canada Pension Plan Investment Board
48
Canada Pension Plan Investment Board
Ontario, Canada
– -$23.3M -592,000 Closed
EMFAT
49
Emerald Mutual Fund Advisers Trust
Pennsylvania
– -$23M -584,464 Closed
Bank of New York Mellon
50
Bank of New York Mellon
New York
– -$22.1M -561,251 Closed
1
2
3 4 5

ISEE Hedge Fund Activity: Q3 2023 in Review

0 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2023, worth a combined $0 — down 100% from $5.32B a quarter earlier.

Sellers outnumbered buyers: 254 funds closed out of ISEE and 0 opened new positions — a net loss of 254 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $538M sold.

  • 0 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2023, down from 256 in Q2 2023.
  • Funds reported $0 of IVERIC bio, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
  • 0 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2023 and 254 closed out, a net change of -254 holders.
  • The largest IVERIC bio, Inc. Common Stock seller in Q3 2023 was Vanguard Group, an estimated $538M sold.

Based on aggregated 13F filings for Q3 2023.